Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of RUC-4 in STEMI Patients
NCT04284995Phase 2Completed
- Sponsor
- CeleCor Therapeutics
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zalunfiban in ST elevation myocardial infarction (STEMI), sponsored by CeleCor Therapeutics. Started Jun 2020; status: completed.
02
Drugs
zalunfiban
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04284995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04284995.